TransMedics Group, Inc. Operating Cash Flow
TransMedics Group, Inc. (TMDX) reported Operating Cash Flow of $41.84 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-04
- TransMedics Group, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $17.31M, a 81.11% decline year-over-year.
- TransMedics Group, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $24.53M.
- TransMedics Group, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $34.51M, a 75.52% increase year-over-year.
- TransMedics Group, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $69.57M, a 914.63% increase year-over-year.
- TransMedics Group, Inc. net cash provided by (used in) operating activities for fiscal 2025 was $192.84M, a 295.14% increase from fiscal 2024.
- TransMedics Group, Inc. net cash provided by (used in) operating activities for fiscal 2024 was $48.80M.
- TransMedics Group, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$13.03M.
- TransMedics Group, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$45.82M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $17.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $41.84M 10-Q · filed 2026-08-04 | $76.36M derived: sum of 3 quarters · filed 2026-08-04 | $145.93M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $24.53M 10-Q · filed 2026-05-05 | $59.05M derived: sum of 2 quarters · filed 2026-05-05 | $128.62M derived: sum of 3 quarters · filed 2026-05-05 | $220.23M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $34.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $104.09M derived: sum of 2 quarters · filed 2026-02-24 | $195.69M derived: sum of 3 quarters · filed 2026-08-04 | $192.84M 10-K · filed 2026-02-24 |
| 2025-09-30 | $69.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $161.18M derived: sum of 2 quarters · filed 2026-08-04 | $158.33M 10-Q · filed 2025-10-29 | $177.99M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $91.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $88.75M 10-Q · filed 2026-08-04 | $108.42M derived: sum of 3 quarters · filed 2026-08-04 | $115.27M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$2.85M 10-Q · filed 2026-05-05 | $16.81M derived: sum of 2 quarters · filed 2026-05-05 | $23.66M derived: sum of 3 quarters · filed 2026-05-05 | $49.38M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $19.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $26.52M derived: sum of 2 quarters · filed 2026-02-24 | $52.24M derived: sum of 3 quarters · filed 2026-02-24 | $48.80M 10-K · filed 2026-02-24 |
| 2024-09-30 | $6.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $32.58M derived: sum of 2 quarters · filed 2025-10-29 | $29.14M 10-Q · filed 2025-10-29 | $37.44M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $25.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $22.28M 10-Q · filed 2025-07-30 | $30.59M derived: sum of 3 quarters · filed 2026-02-24 | $23.72M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | -$3.44M 10-Q · filed 2025-05-08 | $4.87M derived: sum of 2 quarters · filed 2026-02-24 | -$2.00M derived: sum of 3 quarters · filed 2026-02-24 | -$7.80M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $8.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.44M derived: sum of 2 quarters · filed 2026-02-24 | -$4.37M derived: sum of 3 quarters · filed 2026-02-24 | -$13.03M 10-K · filed 2026-02-24 |
| 2023-09-30 | -$6.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$12.67M derived: sum of 2 quarters · filed 2024-10-29 | -$21.33M 10-Q · filed 2024-10-29 | -$25.37M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$5.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$14.46M 10-Q · filed 2024-08-01 | -$18.50M derived: sum of 3 quarters · filed 2025-02-27 | -$32.78M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$8.66M 10-Q · filed 2024-05-02 | -$12.70M derived: sum of 2 quarters · filed 2025-02-27 | -$26.98M derived: sum of 3 quarters · filed 2025-02-27 | -$36.07M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$4.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$18.32M derived: sum of 2 quarters · filed 2025-02-27 | -$27.41M derived: sum of 3 quarters · filed 2025-02-27 | -$45.82M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$14.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$23.38M derived: sum of 2 quarters · filed 2023-11-08 | -$41.78M 10-Q · filed 2023-11-08 | -$48.43M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$9.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$27.50M 10-Q · filed 2023-08-04 | -$34.15M derived: sum of 3 quarters · filed 2024-02-27 | -$43.50M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$18.41M 10-Q · filed 2023-05-04 | -$25.05M derived: sum of 2 quarters · filed 2024-02-27 | -$34.40M derived: sum of 3 quarters · filed 2024-02-27 | -$39.94M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$6.65M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$16.00M derived: sum of 2 quarters · filed 2024-02-27 | -$21.53M derived: sum of 3 quarters · filed 2024-02-27 | -$28.86M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$9.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$14.89M derived: sum of 2 quarters · filed 2022-11-04 | -$22.22M 10-Q · filed 2022-11-04 | -$29.35M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | -$5.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$12.87M 10-Q · filed 2022-08-03 | -$20.00M derived: sum of 3 quarters · filed 2023-02-27 | -$26.42M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | -$7.33M 10-Q · filed 2022-05-05 | -$14.47M derived: sum of 2 quarters · filed 2023-02-27 | -$20.88M derived: sum of 3 quarters · filed 2023-02-27 | -$29.42M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | -$7.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$13.55M derived: sum of 2 quarters · filed 2023-02-27 | -$22.09M derived: sum of 3 quarters · filed 2023-02-27 | -$30.27M 10-K · filed 2023-02-27 |
| 2020-09-30 | -$6.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$14.95M derived: sum of 2 quarters · filed 2021-11-09 | -$23.13M 10-Q · filed 2021-11-09 | -$30.39M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$8.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$16.71M 10-Q · filed 2021-08-06 | -$23.98M derived: sum of 3 quarters · filed 2021-05-07 | -$29.58M derived: sum of 4 quarters · filed 2021-05-07 |
| 2020-03-31 | -$8.18M 10-Q · filed 2021-05-07 | -$15.44M derived: sum of 2 quarters · filed 2021-05-07 | -$21.04M derived: sum of 3 quarters · filed 2021-05-07 | -$33.20M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-28 | -$7.26M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$12.86M derived: sum of 2 quarters · filed 2021-03-11 | -$25.02M derived: sum of 3 quarters · filed 2021-03-11 | -$32.29M 10-K · filed 2021-03-11 |
| 2019-09-28 | -$5.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$17.76M derived: sum of 2 quarters · filed 2020-08-07 | -$25.02M 10-Q · filed 2019-11-08 | |
| 2019-06-29 | -$12.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$19.43M 10-Q · filed 2020-08-07 | ||
| 2019-03-30 | -$7.27M 10-Q · filed 2020-05-06 | |||
| 2018-12-29 | -$25.98M 10-K · filed 2020-03-17 | |||
| 2018-09-29 | -$19.86M 10-Q · filed 2019-11-08 | |||
| 2018-06-30 | -$7.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$13.80M 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | -$6.33M 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |